NCT01168973 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 628
- group Id
- BG001
- value
- 625
- group Id
- BG002
- value
- 1253
- units
- Participants
- groups
- description
- On Day 1 of each 21-day cycle, participants received ramucirumab DP followed by docetaxel. Treatment continued until disease progression, unacceptable toxicity, or other withdrawal criteria were met. * Ramucirumab DP: 10 mg/kg administered intravenously. * Docetaxel: 75 mg/m\^2 (60 mg/m\^2 for the countries of Korea and Taiwan only, with protocol amendment dated 22 May 2012) administered intravenously.
- id
- BG000
- title
- Ramucirumab and Docetaxel
- description
- On Day 1 of each 21-day cycle, participants received placebo followed by docetaxel. Treatment continued until disease progression, unacceptable toxicity, or other withdrawal criteria were met. * Placebo (matching Ramucirumab DP): 10 mg/kg administered intravenously. * Docetaxel: 75 mg/m\^2 (60 mg/m\^2 for the countries of Korea and Taiwan only, with protocol amendment dated 22 May 2012) administered intravenously.
- id
- BG001
- title
- Placebo and Docetaxel
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 391
- group Id
- BG001
- value
- 407
- group Id
- BG002
- value
- 798
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 237
- group Id
- BG001
- value
- 218
- group Id
- BG002
- value
- 455
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 209
- group Id
- BG001
- value
- 210
- group Id
- BG002
- value
- 419
- title
- Female
- measurements
- group Id
- BG000
- value
- 419
- group Id
- BG001
- value
- 415
- group Id
- BG002
- value
- 834
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 53
- group Id
- BG002
- value
- 96
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 387
- group Id
- BG001
- value
- 380
- group Id
- BG002
- value
- 767
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 198
- group Id
- BG001
- value
- 192
- group Id
- BG002
- value
- 390
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 29
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 160
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 33
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 526
- group Id
- BG001
- value
- 503
- group Id
- BG002
- value
- 1029
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 156
- group Id
- BG001
- value
- 152
- group Id
- BG002
- value
- 308
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 27
- title
- Taiwan
- categories
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 44
- title
- Greece
- categories
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 50
- title
- Spain
- categories
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 22
- title
- Israel
- categories
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 61
- title
- Russian Federation
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 54
- title
- Italy
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 26
- title
- Switzerland
- categories
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 55
- title
- India
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 45
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- Puerto Rico
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 31
- title
- Netherlands
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- population Description
- Intent-to-Treat (ITT) population: All randomized participants grouped according to their assigned treatment at randomization.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 628
- group Id
- BG001
- value
- 625
- group Id
- BG002
- value
- 1253
- units
- Participants
- groups
- description
- On Day 1 of each 21-day cycle, participants received ramucirumab DP followed by docetaxel. Treatment continued until disease progression, unacceptable toxicity, or other withdrawal criteria were met. * Ramucirumab DP: 10 mg/kg administered intravenously. * Docetaxel: 75 mg/m\^2 (60 mg/m\^2 for the countries of Korea and Taiwan only, with protocol amendment dated 22 May 2012) administered intravenously.
- id
- BG000
- title
- Ramucirumab and Docetaxel
- description
- On Day 1 of each 21-day cycle, participants received placebo followed by docetaxel. Treatment continued until disease progression, unacceptable toxicity, or other withdrawal criteria were met. * Placebo (matching Ramucirumab DP): 10 mg/kg administered intravenously. * Docetaxel: 75 mg/m\^2 (60 mg/m\^2 for the countries of Korea and Taiwan only, with protocol amendment dated 22 May 2012) administered intravenously.
- id
- BG001
- title
- Placebo and Docetaxel
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 391
- group Id
- BG001
- value
- 407
- group Id
- BG002
- value
- 798
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 237
- group Id
- BG001
- value
- 218
- group Id
- BG002
- value
- 455
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 209
- group Id
- BG001
- value
- 210
- group Id
- BG002
- value
- 419
- title
- Female
- measurements
- group Id
- BG000
- value
- 419
- group Id
- BG001
- value
- 415
- group Id
- BG002
- value
- 834
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 53
- group Id
- BG002
- value
- 96
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 387
- group Id
- BG001
- value
- 380
- group Id
- BG002
- value
- 767
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 198
- group Id
- BG001
- value
- 192
- group Id
- BG002
- value
- 390
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 29
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 160
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 33
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 526
- group Id
- BG001
- value
- 503
- group Id
- BG002
- value
- 1029
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 156
- group Id
- BG001
- value
- 152
- group Id
- BG002
- value
- 308
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 27
- title
- Taiwan
- categories
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 44
- title
- Greece
- categories
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 50
- title
- Spain
- categories
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 22
- title
- Israel
- categories
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 61
- title
- Russian Federation
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 54
- title
- Italy
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 26
- title
- Switzerland
- categories
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 55
- title
- India
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 45
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- Puerto Rico
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 31
- title
- Netherlands
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- population Description
- Intent-to-Treat (ITT) population: All randomized participants grouped according to their assigned treatment at randomization.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle